Atrial Fibrillation Trial, Recruiting NCT07441382 Sponsor: Guangdong Provincial People's Hospital Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07441382
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 75 years old or older
  • You have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF) that is not caused by a heart valve problem
  • Your doctor has calculated that you have a high risk of stroke based on a standard scoring system (a score of 3 or higher on a scale called CHA2DS2-VASc)
  • Either you already had a catheter ablation procedure (a treatment for AF) between 90 and 180 days ago, OR you are scheduled to have one within 10 days of joining the trial
  • Your doctor believes you can safely take the blood-thinning medicines required by this study
  • You are able to have a specialised heart scan (either through your throat or using a CT scanner of your chest)
  • You are willing and able to sign the consent form agreeing to take part
  • You are willing to come back for all follow-up appointments and check-ups during the trial

Who may not be able to join:

  • A scan has found a blood clot in a specific part of your heart (the left atrium or left atrial appendage)
  • You had a serious bleeding episode in the 14 days before joining, or treatment for bleeding is still planned
  • You need to take blood thinners long-term for a reason other than your AF, and you would not be able to stop taking them after a device is fitted
  • You had a heart procedure or major surgery (other than your AF ablation or a heart rhythm reset) in the 30 days before joining, or one is planned within 60 days after joining
  • Your life expectancy is less than 2 years, or you have an active cancer, a heart infection, an uncontrolled infection, or fluid pressing on your heart
  • Your level of frailty falls at either the very fit/non-frail end (score 1–3) or the severely frail/terminally ill end (score 7–9) on a standard frailty scale (confirm with trial site)
  • Your doctor considers blood-thinning medicines unsuitable for you due to bleeding risk, allergies, or other concerns
  • You are currently taking part in another clinical trial that could affect this study
  • You had a stroke or a mini-stroke (TIA) in the 60 days before joining
  • You had a heart attack in the 90 days before joining
  • You have had a previous repair of a hole in the heart (ASD), or you already have a device fitted to close a hole in the heart
  • You have an artificial (mechanical) heart valve anywhere in your heart
  • You are pregnant or planning to become pregnant during the study
  • You have a physical reason that makes a catheter-based procedure through a blood vessel unsafe for you
  • You have been diagnosed with the most severe level of heart failure (NYHA Class IV)
  • You have previously had surgery to close off a small pouch in your heart called the left atrial appendage

Additional reasons you may not be able to join based on a heart ultrasound (echocardiogram):

  • Your heart's pumping strength is very low (less than 30% on a measure called ejection fraction)
  • You have fluid around your heart measuring more than 5mm all the way around
  • You have a combination of a hole between the upper chambers of your heart and a bulging wall between those chambers measuring more than 15mm (confirm with trial site)
  • You have a hole between the upper chambers of your heart with a large amount of blood flowing through it, detected by a bubble test (confirm with trial site)
  • You have moderate or severe narrowing of your mitral heart valve

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 086 13570082363

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Guangdong Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
24 March 2026
Est. completion
1 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of Net Adverse Clinical Events (NACE) at 12 Months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov